{"id":12528,"date":"2024-10-11T20:02:12","date_gmt":"2024-10-11T18:02:12","guid":{"rendered":"https:\/\/valintermed.com\/?p=12528"},"modified":"2024-10-11T20:02:12","modified_gmt":"2024-10-11T18:02:12","slug":"pervichnaya-mediastinalnaya-v-kletochnaya-limfoma-pmvkl","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/primary-mediastinal-v-cellular-lymphoma-pmvkl\/","title":{"rendered":"Primary mediastinal B-cell lymphoma (PMBCL)"},"content":{"rendered":"
<\/div>\n

Primary mediastinal B-cell lymphoma (PMBCL) is a rare malignancy that arises from B lymphocytes and is predominantly localized in the mediastinum, the area between the lungs. This form of lymphoma belongs to the group of non-Hodgkin lymphomas and can develop in both young people and adults. PMBCL usually presents with enlarged lymph nodes, which may be accompanied by symptoms such as cough, shortness of breath, and chest pain, depending on the size and location of the tumor. Because this disease can be aggressive, early diagnosis and adequate treatment are important to improve the prognosis of patients. Because PMBCL differs significantly from other forms of lymphoma in both clinical manifestations and treatment approaches, a more detailed study of this disease allows us to better understand its nature and methods of management.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n